RWPA
Richard W. Paul & Associates’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
7,372
-202
| -3% | -$37.5K | 0.49% | 45 |
|
|
2025
Q1 | $1.59M | Sell |
7,574
-179
| -2% | -$37.5K | 0.62% | 33 |
|
|
2024
Q4 | $1.38M | Buy |
7,753
+307
| +4% | +$54.6K | 0.5% | 49 |
|
|
2024
Q3 | $1.47M | Sell |
7,446
-146
| -2% | -$28.8K | 0.53% | 44 |
|
|
2024
Q2 | $1.3M | Sell |
7,592
-880
| -10% | -$151K | 0.5% | 46 |
|
|
2024
Q1 | $1.54M | Sell |
8,472
-302
| -3% | -$55K | 0.62% | 40 |
|
|
2023
Q4 | $1.36M | Sell |
8,774
-80
| -0.9% | -$12.4K | 0.57% | 44 |
|
|
2023
Q3 | $1.32M | Sell |
8,854
-1,203
| -12% | -$179K | 0.6% | 39 |
|
|
2023
Q2 | $1.35M | Buy |
10,057
+363
| +4% | +$48.9K | 0.59% | 46 |
|
|
2023
Q1 | $1.55M | Sell |
9,694
-89
| -0.9% | -$14.2K | 0.71% | 38 |
|
|
2022
Q4 | $1.58M | Buy |
+9,783
| New | +$1.58M | 0.8% | 32 |
|